Jaguar Health, Inc. (JAGX) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001585608 · SEC filings checked Oct 18, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 19, 2026 | $1.2M | — | $-15.70 | Filing |
| Mar 31, 2026 | May 20, 2026 | $20.3M | — | $-13.60 | Filing |
| Dec 31, 2025 | Apr 7, 2026 | $3.2M | $30.3M | $926.70 | Filing |
| Sep 30, 2025 | Nov 14, 2025 | $3.1M | $-9.5M | $-6.28 | Filing |
| Jun 30, 2025 | Aug 14, 2025 | $3.0M | $-10.4M | $-358.94 | Filing |
| Mar 31, 2025 | May 15, 2025 | $2.2M | $-10.5M | $-584.45 | Filing |
| Dec 31, 2024 | Mar 31, 2025 | $3.5M | $28.5M | $-14.62 | Filing |
| Sep 30, 2024 | Nov 13, 2024 | $3.1M | $-9.9M | $-26.29 | Filing |
What would Jaguar Health, Inc. have to report for its valuation to change?
At $2.29, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -81.4% a year, to $0.20. On that path the next quarter needs diluted EPS near $-1.17, against $-6.28 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | -81.4% | -81.4% |
| EPS needed in final year | $0.20 | $0.20 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. JAGX goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.